SALT LAKE CITY, UT / ACCESS Newswire / January 28, 2025 / With Revenues 19% lower, Net Income 17% lower and Earnings Per Share (EPS) 13% lower than in 2023, Utah Medical Products, Inc. (NASDAQ:UTMD) c ...
Citi's latest Dollar Index (DXY) fair value model revealed a minimal residual overvaluation of just +0.1%, a stark decrease from the previous high of +3.4%. This valuation adjustment has occurred ...